id,group_id,source,exact,prefix,suffix,anno_type,position_type,start,end,tags,all,origin_tags,comment,user,title,created
ypoWbsYoEemvdEOhdcvzxA,3NabqAPM,https://europepmc.org/articles/PMC5770482/,depression,"es, pain/discomfort and anxiety/",. Each dimension includes five s,TextQuoteSelector,TextPositionSelector,15063,15073,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:36:50.881010+00:00
wraorsYoEemDRrMUCmBMhQ,3NabqAPM,https://europepmc.org/articles/PMC5770482/, anxiety," activities, pain/discomfort and",/depression. Each dimension incl,TextQuoteSelector,TextPositionSelector,15054,15062,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:36:37.734427+00:00
sTsVMsYpEemopQP_mUTrAQ,3NabqAPM,https://europepmc.org/articles/PMC5770482/,Lactate dehydrogenase ," serum calcium>ULN, n (%)26 (30)",">1.5 times ULN, n (%)11 (12)Time",TextQuoteSelector,TextPositionSelector,20277,20299,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:43:17.802898+00:00
pta8csYpEem5LacG4hsgOA,3NabqAPM,https://europepmc.org/articles/PMC5770482/,Haemoglobin,"(24)Brain metastasis, n (%)3 (3)","<LLN, n (%)46 (52)Neutrophil cou",TextQuoteSelector,TextPositionSelector,20141,20152,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:43:00.260500+00:00
jatz8MYpEemmb-tQlNm6aw,3NabqAPM,https://europepmc.org/articles/PMC5770482/,(m)RCC,uate treatment of patients with , in the Netherlands. HRQoL was m,TextQuoteSelector,TextPositionSelector,10183,10189,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:42:18.242993+00:00
iyOdaMWpEem0zwckT-Odig,3NabqAPM,https://europepmc.org/articles/PMC5770482/,Cancer,". Additionally, the Netherlands "," Registry (NCR), which maintains",TextQuoteSelector,TextPositionSelector,13965,13971,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-23T13:25:58.372946+00:00
hY323spXEemauhucIfJbjg,3NabqAPM,https://europepmc.org/articles/PMC5770482/,bone metastases,NSNSNSNS0.300*0.191 Presence of ,4.733**2.961NS15.054***14.768NSN,TextQuoteSelector,TextPositionSelector,29761,29776,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-29T12:21:26.058716+00:00
fDkGlsYpEemdv8cP7OiSMQ,3NabqAPM,https://europepmc.org/articles/PMC5770482/,mRCC,etastatic renal cell carcinoma (,) have been approved. It is assu,TextQuoteSelector,TextPositionSelector,9708,9712,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:41:48.993523+00:00
byg4RsYpEemsU1NsVxPTUQ,3NabqAPM,https://europepmc.org/articles/PMC5770482/,Metastatic renal cell carcinoma,"0, Cost-effectiveness analysis, ",", Targeted therapyGo to:Introduc",TextQuoteSelector,TextPositionSelector,11514,11545,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:41:26.948889+00:00
YlfCdsWnEemXTTcrbxB8Kg,3NabqAPM,https://europepmc.org/articles/PMC5770482/,venous thromboembolism,"/or fatigue, pain, anaemia, and "," [3].Since 2006, several new tar",TextQuoteSelector,TextPositionSelector,12185,12207,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-23T13:10:30.740620+00:00
WganrsWnEem-yt8mRzZ1cw,3NabqAPM,https://europepmc.org/articles/PMC5770482/, anaemia,", asthenia and/or fatigue, pain,",", and venous thromboembolism [3]",TextQuoteSelector,TextPositionSelector,12171,12179,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-23T13:10:16.905533+00:00
WW9GNMYpEemDl5cS90s4pg,3NabqAPM,https://europepmc.org/articles/PMC5770482/,Rem,omic evaluation of sunitinib by ,ák and colleagues [25] was based,TextQuoteSelector,TextPositionSelector,33182,33185,WT_DS,no,[WT_DS],,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:40:50.586547+00:00
ToxXrMYpEem3aSvdZSttAA,3NabqAPM,https://europepmc.org/articles/PMC5770482/,Hypertension ,verse events is relatively low. ,and fatigue are the most commonl,TextQuoteSelector,TextPositionSelector,36073,36086,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:40:32.229599+00:00
RTpBlsYpEemdvq-zhH5ziA,3NabqAPM,https://europepmc.org/articles/PMC5770482/,progressive disease,and 0.70 (95% CI 0.66–0.74) for ,. These utilities were derived f,TextQuoteSelector,TextPositionSelector,32961,32980,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:40:16.718632+00:00
Nsn8ZMYpEemiwEeBOtwX1A,3NabqAPM,https://europepmc.org/articles/PMC5770482/,lung metastases,0.05NS−3.9924.779NS Presence of ,−0.0210.041NS0.4654.074NS Presen,TextQuoteSelector,TextPositionSelector,26553,26568,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:39:52.476093+00:00
Mm5JrsWnEemi4JtkYzElCg,3NabqAPM,https://europepmc.org/articles/PMC5770482/,anorexia,"mptoms, such as cachexia and/or ",", asthenia and/or fatigue, pain,",TextQuoteSelector,TextPositionSelector,12131,12139,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-23T13:09:10.567631+00:00
MGmAYMYpEemmg4_f0VOrWA,3NabqAPM,https://europepmc.org/articles/PMC5770482/,liver metastases,0483.3424.048*2.276 Presence of ,−0.0270.05NS−3.9924.779NS Presen,TextQuoteSelector,TextPositionSelector,26499,26515,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:39:41.746187+00:00
KBn3ZMYpEemjRy8DG4fMVg,3NabqAPM,https://europepmc.org/articles/PMC5770482/,bone metastases,ore than one metastatic site or ," reported a lower EQ-5D utility,",TextQuoteSelector,TextPositionSelector,25565,25580,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:39:27.849194+00:00
JuGiesWnEemVcp90_zY68A,3NabqAPM,https://europepmc.org/articles/PMC5770482/,metastatic disease,is of patients with advanced or , is poor. Median overall surviva,TextQuoteSelector,TextPositionSelector,11791,11809,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-23T13:08:51.005682+00:00
IPCeIMYpEemdvfs3sXQkSw,3NabqAPM,https://europepmc.org/articles/PMC5770482/,brain metastases , HRQoL (Table 3). Patients with ,and patients with progression of,TextQuoteSelector,TextPositionSelector,25412,25429,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:39:15.821107+00:00
IB_hVMWnEemu7EviMARHKA,3NabqAPM,https://europepmc.org/articles/PMC5770482/,localised disease , the prognosis of patients with ,treated with surgery is relative,TextQuoteSelector,TextPositionSelector,11689,11707,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-23T13:08:39.738727+00:00
FpPnhMWnEemDKuNFUZSPSg,3NabqAPM,https://europepmc.org/articles/PMC5770482/,kidney cancers,a (RCC) accounts for 90% of all , [1]. While the prognosis of pat,TextQuoteSelector,TextPositionSelector,11632,11646,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-23T13:08:23.600568+00:00
FmaG7spYEem5_9PuQXXkOw,3NabqAPM,https://europepmc.org/articles/PMC5770482/, lung metastases,s4.427*3.395NSNSNSNS Presence of,NSNSNSNS0.300*0.191 Presence of ,TextQuoteSelector,TextPositionSelector,29713,29729,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-29T12:25:29.088950+00:00
FcAK4MWnEemm6WvjDBp2Jg,3NabqAPM,https://europepmc.org/articles/PMC5770482/,RCC,troductionRenal cell carcinoma (,) accounts for 90% of all kidney,TextQuoteSelector,TextPositionSelector,11603,11606,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-23T13:08:21.870462+00:00
BS1E6sWnEem_hWcDGerH4g,3NabqAPM,https://europepmc.org/articles/PMC5770482/,Renal cell carcinoma,rgeted therapyGo to:Introduction, (RCC) accounts for 90% of all k,TextQuoteSelector,TextPositionSelector,11581,11601,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-23T13:07:54.457211+00:00
6G9cqMYoEemEs68lFfqjzg,3NabqAPM,https://europepmc.org/articles/PMC5770482/,Brain metastasis,"56)Bone metastasis, n (%)21 (24)",", n (%)3 (3)Haemoglobin<LLN, n (",TextQuoteSelector,TextPositionSelector,20113,20129,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:37:41.019378+00:00
5BZM_MYoEemEsqdDR5xQbg,3NabqAPM,https://europepmc.org/articles/PMC5770482/,Bone metastasis,"17)Lung metastasis, n (%)48 (56)",", n (%)21 (24)Brain metastasis, ",TextQuoteSelector,TextPositionSelector,20084,20099,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:37:33.744450+00:00
4Cc1osYoEem2gUc5ZxWvFg,3NabqAPM,https://europepmc.org/articles/PMC5770482/,Lung metastasis,"5)Liver metastasis, n (%)15 (17)",", n (%)48 (56)Bone metastasis, n",TextQuoteSelector,TextPositionSelector,20055,20070,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:37:27.041682+00:00
3Z1QDsYpEemeuXMIGiGavg,3NabqAPM,https://europepmc.org/articles/PMC5770482/,cytokine, with progression on first-line , therapy were enrolled in the ph,TextQuoteSelector,TextPositionSelector,33763,33771,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:44:32.291434+00:00
2lNCOMYoEemgNyceleMDjA,3NabqAPM,https://europepmc.org/articles/PMC5770482/,Liver metastasis,"ne metastatic site, n (%)48 (55)",", n (%)15 (17)Lung metastasis, n",TextQuoteSelector,TextPositionSelector,20025,20041,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-24T04:37:17.244383+00:00
2EFgCspXEemaoIOUDepAlg,3NabqAPM,https://europepmc.org/articles/PMC5770482/, liver metastases,ease characteristics Presence of,4.427*3.395NSNSNSNS Presence of ,TextQuoteSelector,TextPositionSelector,29665,29682,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-29T12:23:44.686407+00:00
-xketsWmEem0PFNb99tGtQ,3NabqAPM,https://europepmc.org/articles/PMC5770482/,metastatic renal cell carcinoma," survival (PFS), new agents for ", (mRCC) have been approved. It i,TextQuoteSelector,TextPositionSelector,9675,9706,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.,2019-08-23T13:07:37.596232+00:00
